London
· Delayed Price · Currency is GBP · Price in GBXOxford BioDynamics Statistics
Total Valuation
Oxford BioDynamics has a market cap or net worth of GBP 13.86 million. The enterprise value is 18.68 million.
| Market Cap | 13.86M |
| Enterprise Value | 18.68M |
Important Dates
The next estimated earnings date is Tuesday, September 17, 2024.
| Earnings Date | Sep 17, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Oxford BioDynamics has 311.86 million shares outstanding. The number of shares has increased by 49.58% in one year.
| Shares Outstanding | 311.86M |
| Shares Change (YoY) | +49.58% |
| Shares Change (QoQ) | +29.80% |
| Owned by Insiders (%) | 3.43% |
| Owned by Institutions (%) | 68.08% |
| Float | 265.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.90 |
| PB Ratio | 5.54 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.68 |
| EV / Sales | 30.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.76 |
Financial Position
The company has a current ratio of 0.68, with a Debt / Equity ratio of 370.22.
| Current Ratio | 0.68 |
| Quick Ratio | 0.62 |
| Debt / Equity | 370.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.89 |
| Interest Coverage | -47.51 |
Financial Efficiency
Return on equity (ROE) is -266.70% and return on invested capital (ROIC) is -70.95%.
| Return on Equity (ROE) | -266.70% |
| Return on Assets (ROA) | -56.23% |
| Return on Capital (ROIC) | -70.95% |
| Revenue Per Employee | 11,642 |
| Profits Per Employee | -209,585 |
| Employee Count | 45 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 1.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.01% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -61.01% |
| 50-Day Moving Average | 7.05 |
| 200-Day Moving Average | 12.58 |
| Relative Strength Index (RSI) | 20.72 |
| Average Volume (20 Days) | 2,228,075 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oxford BioDynamics had revenue of GBP 617,000 and -11.11 million in losses. Loss per share was -0.06.
| Revenue | 617,000 |
| Gross Profit | 256,000 |
| Operating Income | -11.40M |
| Pretax Income | -11.53M |
| Net Income | -11.11M |
| EBITDA | -10.74M |
| EBIT | -11.40M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 1.19 million in cash and 6.01 million in debt, giving a net cash position of -4.82 million or -0.02 per share.
| Cash & Cash Equivalents | 1.19M |
| Total Debt | 6.01M |
| Net Cash | -4.82M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 1.62M |
| Book Value Per Share | 0.01 |
| Working Capital | -1.23M |
Cash Flow
In the last 12 months, operating cash flow was -6.54 million and capital expenditures -224,000, giving a free cash flow of -6.77 million.
| Operating Cash Flow | -6.54M |
| Capital Expenditures | -224,000 |
| Free Cash Flow | -6.77M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | 41.49% |
| Operating Margin | -1,848.14% |
| Pretax Margin | -1,869.37% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,096.60% |
Dividends & Yields
Oxford BioDynamics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.58% |
| Shareholder Yield | -49.58% |
| Earnings Yield | -139.54% |
| FCF Yield | -48.81% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |